Background-For patients with in-hospital cardiac arrests due to non-shockable rhythms, delays in epinephrine administration beyond 5 minutes is associated with worse survival. However, the extent of hospital variation in delayed epinephrine administration and its impact on hospital-level outcomes is unknown.
Clinical Perspective

What is new?
In a large national registry, we found that delays in epinephrine administration (>5 minutes) for non-shockable in-hospital cardiac arrest varied substantially across hospitals.
Hospitals with higher rates of delays in epinephrine treatment had worse survival outcomes for its cardiac arrest patients.
What are the clinical implications?
While current resuscitation guidelines recommend prompt delivery of epinephrine treatment to patients with in-hospital cardiac arrest due to asystole and pulseless electrical activity, there is substantial practice variation across hospitals.
Our findings suggest that hospitals with low survival rates for these cardiac arrest rhythms may benefit from quality improvement efforts that include minimizing delays in epinephrine administration.
Our findings suggest that hospitals with low survival rates for these cardiac c ar ar arre re est st st rh rh rhyt yt yth hm h s may benefit from quality improvement efforts that include minimizing delays in epinephrine administration.
Introduction
More than 80% of in-hospital cardiac arrests are due to a non-shockable rhythm -namely asystole and pulseless electrical activity (PEA). 1 Clinical guidelines recommend epinephrine within 3-5 minutes of onset of cardiac arrest for improving survival for asystole and PEA. 2, 3 However, delays in epinephrine administration are common, 4 and incremental delays in administration of epinephrine in non-shockable in-hospital cardiac arrests are associated with progressively worse survival. 4, 5 Based on these studies, some have advocated for adopting time to epinephrine administration as a hospital quality-metric for in-hospital resuscitation care.
It is conceivable that hospital efforts aimed at improving timely administration of epinephrine could potentially improve survival in this population where survival rates have been traditionally poor. The extent of hospital variation in delayed epinephrine administration, however, remains largely unknown. Quantifying hospital variation in delayed epinephrine administration, and its association with hospital factors and outcomes, would be important to understand in order to determine whether this gap in care is pervasive across hospitals or isolated to specific hospital groups.
To address this gap in knowledge, we used data from the Get With The GuidelinesResuscitation registry to examine hospital-level variation in rates of delayed epinephrine administration and whether certain hospital characteristics are associated with higher or lower rates of delays. Moreover, we examined the implications of hospital variation by determining the association between a hospital's rate of delayed epinephrine treatment and its rate of overall survival and survival with functional recovery for patients with non-shockable in-hospital cardiac arrest.
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Methods
Data Sources
We used data from the the American Heart Association's Get With The Guidelines®-Resuscitation, a large prospective, hospital-based clinical registry of in-hospital cardiac arrest.
The design of the registry has been described previously. 1 Briefly, all patients with an in-hospital cardiac arrest, defined as absence of pulse, apnea, and unresponsiveness, without do-notresuscitate orders, and who received cardiopulmonary resuscitation are identified and enrolled by trained personnel. To ensure completeness, multiple case-finding approaches are used, including a centralized collection of cardiac arrest code-sheets, review of hospital paging system logs, pharmacy records, hospital billing charges for resuscitation medication supplies, and routine checks of code carts. 6 Data collection in the registry is based on the Utstein template, which is a standardized template of reporting on cardiac arrest. 7, 8 A number of measures have been implemented to further ensure data completeness and accuracy. These include rigorous training and certification of hospital staff, use of standardized software with internal logic checks, and periodic re-abstraction of data to ensure submitted records are accurate, with one particular data audit revealing an error rate of 2.4%. 6 Matched data from American Hospital Association survey was used to obtain corresponding information on hospital characteristics.
Study population and variables
We identified 123,649 adults with an index in-hospital cardiac arrest due to asystole or PEA in a hospital ward or intensive care unit (ICU) from January 1, 2000 to December 31, 2014. Given the different etiologies, staffing, and circumstances associated with cardiac arrest in the emergency department and procedural areas, cardiac arrests in these locations were not included in our study. Since our primary focus was to evaluate delays in epinephrine pharmacy records, hospital billing charges for resuscitation medication supplies, an an nd d d ro ro rout ut utin in ine e e checks of code carts. 6 Data collection in the registry is based on the Utstein template, which is a tandardized template of reporting on cardiac arrest. 7, 8 A number of measures have been mpl pl p e e emented to to to fu u urt rt rthe e er r en en ensu sure re e d d dat at ata a a co c mp mpletene ne n ss s an nd ac ac accu cu cura ra racy c c . . Th Th Thes ese in includ ud ude e e ri ri rigo go gorous us u t t tra ra rain in nin in ing and d d c ce c rtificatio o on n n of of ho osp pital l l s st s aff, use of of standar ar a dize zed d d so so soft ft ftwa ware e wi ith h f f inte tern n na al a logic ch ch c eck ks, and d periodic re-abstractio i n of data to ensure submitted d records are accurate, with h one parti icular da d ta administration, we restricted our cohort to 107,139 patients who received at least one dose of epinephrine during resuscitation, did not receive vasopressin before epinephrine, and had available information regarding timing of epinephrine administration. We further excluded patients with missing data on the primary outcome of survival to discharge, and hospitals with low case-volume (< 10 cases) and missing data on hospital characteristics. Our final cohort comprised 103,932 patients at 548 hospitals (eFigure 1).
Study Variables and Outcomes
The primary exposure variable was time to administration of epinephrine, which was calculated as the difference between the time of first epinephrine administration and the time of cardiac arrest in whole minutes. Epinephrine administration >5 minutes after the recognition of cardiac arrest was defined as delayed, based on current guideline recommendations for administration of epinephrine within 3-5 minutes of cardiac arrest.
2,3
The primary study outcome was survival to discharge, and the secondary outcome was survival with functional recovery. The latter was defined as cerebral performance category (CPC) scores 1 (mild or no neurological disability) or 2 (moderate neurological disability failure, hepatic and renal insufficiency, metastatic malignancy, sepsis, hypotension and fluid/electrolyte disorders), and interventions in place at the time of cardiac arrest (e.g. mechanical ventilation, vasopressors and hemodialysis). In addition, information regarding arrest in whole minutes. Epinephrine administration >5 minutes after the recognit tio io on n n of of of c c car ar ardi di diac ac a arrest was defined as delayed, based on current guideline recommendations for administration of epinephrine within 3-5 minutes of cardiac arrest.
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Statistical analyses
Rates of delayed epinephrine administration for each hospital were calculated, and hospital variation in rates of delayed epinephrine was examined. Hospitals were then categorized into quartiles based on their rate of delayed epinephrine administration. Differences in patient-and hospital-characteristics across hospital quartiles of delayed epinephrine were evaluated using Cochrane-Armitage test for categorical variables and simple linear regression for continuous variables.
Next, we constructed a multivariable hierarchical regression model (patient-and hospitallevel) to examine the relationship of delayed epinephrine administration with patient and hospital factors. Such models account for clustering of patients within each hospital. In these models, we included hospital site as a random effect and adjusted for the above listed patient characteristics as fixed effects. We used the median odds ratio to quantify the extent of hospital variation in rates of delayed administration of epinephrine. The median odds ratio is obtained from a hierarchical model with only patient-level variables, is calculated using the estimate of the variance of the random hospital intercept, and is always greater than 1. For example, a median odds ratio of 1.5 suggests that the odds of delay in epinephrine administration for a patient are 50% higher at one randomly selected hospital compared to another randomly selected hospital for a similar patient. After quantifying the extent of hospital variation in delayed epinephrine administration, we then added hospital characteristics to the hierarchical regression model to Cochrane-Armitage test for categorical variables and simple linear regression for co co ont nt ntin in nuo uo uous us us variables.
Next, we constructed a multivariable hierarchical regression model (patient-and hospitaleve el) l) l) to exam min in ine th th the re re r la la lati ti t on on nsh sh ship ip ip o o of f f de ela layed ep ep e inep ephrin in ne e e ad ad admi m m ni nis st stra ra r ti t on on wit it ith h h pa pa pati ti tien e e t an an and d d ho ho hosp sp spita fact t tor or o s. Such m m mod od o el ls ac accoun un nt t t for cluste er ring of f f p patie ents ts ts w w wit it ithi i hin n each ch hos sp pita a al l. l In thes s se e mo m dels, w we Finally, to examine the association between a hospital's rate of delayed epinephrine administration and its rate of survival to discharge, we first calculated risk-standardized rates of survival to discharge for each hospital using a previously validated methodology. 9 To accomplish this, we constructed a multivariable hierarchical regression model with survival to discharge as the dependent variable. This model adjusted for patient factors, including demographics (age and sex), cardiac arrest characteristics (e.g., initial rhythm and location of arrest -monitored/non-monitored bed), delayed chest compressions (> 1 minute), comorbidities (e.g. myocardial infarction during hospitalization, major trauma, heart failure, diabetes, hepatic and renal insufficiency, metastatic malignancy, sepsis and fluid/electrolyte disorders), interventions in place at the time of cardiac arrest (e.g., mechanical ventilation, vasopressors and hemodialysis) based on the patient-level predictors of survival for in-hospital cardiac arrest in prior reports. 9 We calculated a hospital's risk-standardized survival rate (RSSR) as the ratio of predicted-to-expected number of survivors at each hospital multiplied by the unadjusted survival rate.
The correlation between a hospital's rate of delayed epinephrine administration with its risk-standardized survival was then evaluated using Pearson's correlation. Differences in riskstandardized survival across hospital quartiles by rates of delayed epinephrine use were then described. Additionally, we quantified the proportion of the hospital variation in survival explained by hospital-level differences in rates of delayed epinephrine by including rates of delayed epinephrine use as an additional covariate in the hierarchical risk-adjustment model for survival. 10 Finally, we included hospital characteristics (hospital teaching status, number of beds, e.g. myocardial infarction during hospitalization, major trauma, heart failure, dia abe be ete te tes, s 
Sensitivity analyses
We conducted a number of additional analyses to determine the robustness of our findings. First, in order to determine whether our findings were influenced by our definition of delayed epinephrine administration, we repeated the analysis of our primary outcome using a threshold of 3 minutes instead of 5 minutes to define delayed epinephrine administration. Second, given that delays in epinephrine administration and other aspects of resuscitation response may differ in patients who arrest in an ICU compared to patients who arrest outside an ICU, we repeated our primary analyses of hospital variation in epinephrine administration and its association with riskstandardized survival after restricting our cohort only to patients who arrested outside an ICU.
Finally, since patients on vasopressor therapy prior to the onset of cardiac arrest may not derive benefit from additional epinephrine bolus, we repeated our analyses of hospital-level relationships after excluding patients receiving vasopressor therapy at the time of cardiac arrest.
All analyses were conducted using SAS software, version 9.4 (Cary, NC). Level of significance was set at P<0.05. The study was reviewed by the University of Iowa Institutional
Review Board, which waived the requirement for informed consent because the study used 
Results
Overall, administration of epinephrine was delayed in 12.7% of patients. The proportion of patients with delayed epinephrine treatment varied widely across hospitals and ranged from 0% to 53.8% (Median 13.5%, interquartile range: 9.5% -19.0%, Figure 1 ). Hospitals were categorized into quartiles based on the proportion of patients with delayed epinephrine as follows: Q1:0-9.5%, Q2:9.5-13.5%; Q3:13. .9% i i in n n Q4 Q4 Q4), o or be be be lo o oca ca cate te ted d d in i i th the ICU U U at a a t th he tim m me e e of of of a arr res es st (6 (62. .7% 7 in n n Q1 Q1 Q1 v v vs. 52. 2. .0% 0% 0% i i in n n Q4) ) ) (P (P ( trend < 0.0 .0 .000 00 0 1 1 fo or r all). . . T Th T ey were e a also le e ess s lik ikel ly y y to to to b b be re eceiv iving v vaso so sopr p essor rs rs (30 30.0% in n Q1 vs. 23.5 5% in Q4) or mechanical ventilatio i n (3 ( 6.4% % in Q1 vs. 25. 5 6% % in Q4 Q ) at the time of cardi diac hospital compared to a similar patient at another randomly selected hospital. Among hospital structural characteristics, low hospital case-volume (<100 cases) was the only factor that was associated with delayed epinephrine administration (odds ratio [OR} 1.30, 95% C.I. 1.17, 1.44; P<0.0001; eTable 2 in the online supplement). Hospital teaching status, total number of beds and proportion of ICU beds were not associated with delay in epinephrine administration. After additionally adjusting for hospital characteristics, substantial variation in delayed epinephrine administration persisted (median odds ratio 1.52 (95% C.I: 1.46, 1.58). Figure 2) . Notably, The results of our sensitivity analyses closely aligned with those of our primary analysis.
We redefined delayed epinephrine administration using a cut-off of > 3 min after onset of cardiac arrest. In these analyses, delayed epinephrine administration remained inversely correlated with risk--0.24, P<0.0001), as in our main analyses (eTable 3 in the online supplement). Similarly, after restricting our sample to arrests outside of the ICU, we observed a wide variation in rates of delayed epinephrine use (median OR 1.48, 95% C.I. 1.42, 
Discussion
In a large, multicenter registry of in-hospital cardiac arrests, we found large variation in timely administration of epinephrine for patients with an initial non-shockable rhythm of pulseless electrical activity or asystole. Differences in patient and cardiac arrest characteristics only partly explain the observed hospital-level differences in delayed epinephrine administration. Moreover, rates of overall survival and survival with functional recovery were lower at hospitals with more frequent delays in epinephrine administration compared to hospitals where such delays were less common. In sensitivity analysis, we demonstrated a similar relationship for a definition of n delayed epinephrine use (median OR 1.51, 95% C.I. 1.44, 1.57, eFigure 4) as we we well l ll a a as s s an an an nverse association between a hospital's rate of delayed epinephrine administration and its risk tandardized survival rate ( -0.22, P-value <.0001, eFigure 5), consistent with the results of our prim ma a ary analys s sis is is. Timely administration of epinephrine in patients with non-shockable rhythm has been proposed as a metric to assess hospital resuscitation quality, similar to time to defibrillation in patients with a shockable rhythm. However, contemporary evidence regarding the efficacy of epinephrine remains uncertain. The only randomized controlled trial that has evaluated epinephrine against placebo in patients with out-of-hospital cardiac arrest was terminated early due to poor enrolment. Only 600 patients were enrolled, compared to a projected sample size of 5000 patients. 11 Treatment with epinephrine compared to placebo was associated with a nearly three-fold improvement in rates of ROSC (23.5% with epinephrine use vs. 8.4% with placebo).
Survival to hospital discharge was also numerically higher in the epinephrine arm (4.0% vs.
1.9%) but was not statistically significant. benefit. 4,5,14,15 A key limitation of studies that showed a detrimental effect of epinephrine was that many of them included patients who did not receive epinephrine as the comparator group, leading to selection bias. 12, 13 Moreover, timing of epinephrine administration -an important confounder, was not accounted for in the analyses. 12, 13 Despite the uncertainty related to epinephrine in clinical studies, recent guidelines recommend administration of epinephrine as soon as feasible after cardiac arrest with initial non-shockable rhythm. 2 Therefore, the large variation in rate of delayed epinephrine administration observed in our study was particularly striking, with a median odds ratio of 1.61. Moreover, delays in epinephrine administration were more common at hospitals with low cardiac arrest case-volume compared to high volume hospitals. This may point toward a lack of institutional experience at low volume sites with regards to resuscitation care as an important underlying factor. We did not find an association between hospital structural factors such as teaching status, or hospital bed size with delays in epinephrine administration. However, this finding wasn't altogether surprising. In a previous study, substantial hospital variation was noted in rates of delayed defibrillation for in-hospital cardiac arrest due to shockable rhythm. 16 However, delays in defibrillation were not associated with hospital structural characteristics, except bed size in that study. These findings suggest that hospital processes of care are likely more important in determining hospital quality. Previous studies have shown that strategies such as more frequent CPR training and participation in simulation or mock codes may help improve retention of CPR skills, improve CPR quality and minimize treatment delays. [17] [18] [19] Understanding hospital-level determinants of delay in epinephrine administration, which may differ across sites, is an important next step.
The Institute of Medicine has recommended focused research on identifying and implementing best practices from hospitals with high survival rates for cardiac arrest to improve hospitals. This may point toward a lack of institutional experience at low volume si si ite te tes s s wi wi w th th th egards to resuscitation care as an important underlying factor. We did not find an association cardiac arrest due to sh hockable rhythm. 16 16 6 However, delays in de d fibr b illati ion were not associated d cardiac arrest outcomes across all hospitals. 20, 21 However, survival for cardiac arrests with an initial rhythm of PEA or asystole remains dismally low at less than 15%. 1 Moreover, few interventions have been effective in reducing the high mortality associated with non-shockable cardiac arrests. Given that patients with asystole or PEA comprise more than 80% of in-hospital cardiac arrests, efforts are urgently needed to identify processes of care that can improve survival in this high-risk population. Although, we found that hospital rate of delayed epinephrine administration was associated with survival outcomes for patients with non-shockable rhythms, our findings suggest a potential target for quality improvement but does not demonstrate causality. Future studies are needed to assess whether interventions directed at improving timeliness of epinephrine administration at poor-performing hospitals leads to an improvement in survival rates at these hospitals.
Our findings should be interpreted in the light of the following limitations. First, while the registry includes detailed information on patient characteristics, there is potential of unmeasured residual confounding in our study due to its observational design. Although we used a robust risk-adjustment methodology, our study doesn't suggest causality. It is possible that delays in epinephrine administration are confounding by other components of cardiopulmonary resuscitation efforts, including quality of chest compressions, which is difficult to quantify and is not measured in the Get With The Guidelines -Resuscitation. Second, functional status has been inferred from CPC scores at discharge. While favorable CPC score at discharge is associated with improved long-term survival, 22 patient performance on dedicated scales for neurological assessment were not available and we were therefore only able to assess functional status. Third, the time to epinephrine administration is obtained from retrospective hospital records, and is subject to discrepancy due to recording of time from multiple clocks in a imeliness of epinephrine administration at poor-performing hospitals leads to an i imp mp mpro ro rove ve v me me ment nt n in urvival rates at these hospitals.
Our findings should be interpreted in the light of the following limitations. First, while he re re egistry inc c clu lu lude de des de de deta a ail il i ed e e i i inf nf nfor or orma m m ti ion o on y pa pa patien ent ch har ar arac ac acte te teri r r st stic ic cs, s, s t the ere r is po po pote te tent nt ntial of of of unme me measured re es esid i i ua ual co confou u un nd n ing in our ur study y y d due e to o o it it its s s ob ob bs ser rvat tio onal l d desi si sign g . Alt t th houg ugh we d used a robust risk-adjustment meth hodology, our study doesn't suggest causali l ty. It is possible code (e.g. the monitor, defibrillator, etc.). 23 Any misclassification in documentation of times, however, would have biased our findings toward the null. Fourth, while there is information on preceding events and comorbid conditions, the specific etiology for cardiac arrest (e.g. trauma)
are not reported. Finally, since participation in the Get With The Guidelines-Resuscitation registry is optional, our data may not be applicable to hospitals outside of those participating in this quality improvement registry.
Conclusions
In conclusion, we found marked variation in the rates of delayed epinephrine administration across hospitals for in-hospital cardiac arrests due to asystole and PEA. This variation is only partly explained by differences in patient-, cardiac arrest-and hospital-characteristics across hospitals. Moreover, hospitals that performed poorly on this metric had worse survival outcomes.
Further investigations are needed to identify the reasons for delayed epinephrine administration at poorly performing hospitals, and to understand if reducing delays to epinephrine treatment results in improved outcomes.
Acknowledgments
Drs. Khera and Girotra had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: All authors
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Khera, Girotra.
Critical revision of the manuscript for important intellectual content: All authors.
across hospitals for in-hospital cardiac arrests due to asystole and PEA. This variat atio io ion n n is is is o o onl nl nly y y partly explained by differences in patient-, cardiac arrest-and hospital-characteristics across hospitals. Moreover, hospitals that performed poorly on this metric had worse survival outcomes Furt rthe h her investig ig igatio io ions s a are re re n nee e ede de ded d d to to to ide ent n ify th h he e re ea ason n ns s s fo fo for r r de d d la laye ye yed d ep pin i ep p phr hr hrin in ine e e ad a a mi i ini ni ist st stra ra rati ti tion o o at p poo oo o rly perfo or ormi mi m n ng h ho ospita ta tals l l , and to u un nderstan an a d if f re e edu du duci ci cing g d delay ays to o e epi i in ne n phrine e e t trea eatment t esults in i improved d outcomes.
Statistical analysis: Khera, Girotra.
Obtained funding: Girotra.
Administrative, technical, or material support: Girotra.
Study supervision: Girotra.
Sources of Funding
Drs. Girotra (K08HL122527) and Chan (K23HL102224, R01HL123980) are supported by the National Heart, Lung, and Blood Institute. Dr. Khera received support from the National Center Q1-Q4: Hospital quartiles for proportion of patients with delayed epinephrine use, Q1 (0 -9.5%), Q2 (9.5 -13.5%), Q3 (13.5 -19.0%) and Q4 (19.0 -53.8%).
4: Hospital quartiles for proportion of patients with delayed epinephrine use, Q1 (0 -9.5%), Q2 (9.5 -13 3.5 .5 5%) %) %), Q3 Q3 Q3 ( ( (13 13 13.5 .5 .5 -%) and Q4 (19.0 -53.8%). 
4: Hospital quartiles for proportion of patients with delayed epinephrine use, Q1 (0 -9.5%), Q2 (9.5 -13 3.5 .5 5%) %) %), Q3 Q3 Q3 ( ( (13 13 Relationship between a hospital's rate of delayed epinephrine administration and its rates of (A)
risk-standardized survival-to--0.22, P<0.0001), (B) risk-standardized survival -0.14,P=0.001). Each circle represents a hospital in the study. 
